Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it ...

Roche Holding AG will add manufacturing capacity in China to serve the country’s growing market, making it the latest ...

With the regulatory approval for advanced breast cancer, Roche’s inavolisib is a potential challenger to Novartis’ PI3K ...

Roche's experimental oral drug for breast cancer giredestrant could enter a market worth at least 10 billion Swiss francs ...

As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a ...

J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

Some trails in the park in central Wisconsin reopened Friday to hikers days after a fire damaged stairway that leads to the ...

Novartis' Piqray/Vijoice (alpelisib) is the only PIK3CA inhibitor to have reached the market for breast cancer, having been ...

Brian Roche – when the consultant becomes the bossHaving begun his public sector career as one of those highly paid ...

Footballer Stephanie Roche has admitted it was “an emotional day” when she hung up her football boots for the final time. On ...

Former business executive and government “fix-it” man Brian Roche has been announced as the next public service ...

Skin care aficionados everywhere are making space for a dermatologist-backed, budget-friendly brand in their medicine ...